|
|
 |
perfect design thanks sandoz telmisartan recall Successful drug development spurred the diversified group's shares to a benchmark-beating 17 percent gain this year but itsMaterialScience unit, a maker of insulation foam chemicals andtransparent plastics, has been hit by high feedstock costs andlower prices amid fierce competition.
2021-2-2 0:31:48 |
|
|
|